medroxyprogesterone acetate has been researched along with Long QT Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ackerman, MJ; Bains, S; Gao, X; Giudicessi, JR; Kim, CJ; Louradour, J; Odening, KE; Pinsky, AM; Tester, DJ | 1 |
| Ackerman, MJ; Brost, BC; Giudicessi, JR; Traynor, KD | 1 |
2 other study(ies) available for medroxyprogesterone acetate and Long QT Syndrome
| Article | Year |
|---|---|
Injectable contraceptive Depo-Provera induces erratic beating patterns in patient-specific induced pluripotent stem cell-derived cardiomyocytes with long QT syndrome type 2.
Topics: Adult; Arrhythmias, Cardiac; Contraceptives, Oral; Female; Humans; Induced Pluripotent Stem Cells; Long QT Syndrome; Medroxyprogesterone Acetate; Myocytes, Cardiac; Progestins | 2023 |
Potential depot medroxyprogesterone acetate-triggered torsades de pointes in a case of congenital type 2 long QT syndrome.
Topics: Adult; Contraceptive Agents, Female; Defibrillators, Implantable; Delayed-Action Preparations; Female; Heart Conduction System; Humans; Hypodermoclysis; Injections, Intramuscular; Long QT Syndrome; Medroxyprogesterone Acetate; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Progesterone; Prosthesis Failure; Tachycardia, Ventricular; Torsades de Pointes | 2012 |